Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
3.760
-0.310 (-7.62%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.56 million as of October 29, 2025. Its market cap has increased by 26.63% in one year.
Market Cap
2.56M
Enterprise Value
-3.92M
1-Year Change
26.63%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.56M, a decrease of -95.54%. That is a compound annual growth rate of -52.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 2.77M | 0.69% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |